The importance of better natural history studies for Duchenne muscular dystrophy.

WHAT IT FOUND

This commentary argues that current natural history studies for Duchenne muscular dystrophy are flawed because they mask patient variability and rely on young cohorts.

It calls for better prospective studies but presents no new evidence.

What this paper is

This is a commentary discussing the limitations of current natural history studies in Duchenne muscular dystrophy. It critiques methodological issues such as uncontrolled variables and the masking of data heterogeneity, but it reports no new patient data or clinical outcomes. There is nothing here to change your practice on.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →